Entries by Jennifer Huynh

Discovery of new T-cell raises prospect of ‘universal’ cancer therapy

Researchers at Cardiff University have discovered a new type of killer T-cell that offers hope of a “one-size-fits-all” cancer therapy. T-cell therapies for cancer – where immune cells are removed, modified and returned to the patient’s blood to seek and destroy cancer cells – are the latest paradigm in cancer treatments. The most widely-used therapy, […]

Our recent coeliac disease research featured in the Age

Coeliac disease linked to bacteria exposure The Age article by Liam Mannix. Original article Exposure to bacteria that mimics gluten can confuse the immune system and trigger coeliac disease, Melbourne scientists have shown for the first time. The results raise the possibility of using probiotics or developing a vaccine to prevent the disease, which affects nearly […]

Bacterial link in coeliac disease

Bacterial exposure has been identified as a potential environmental risk factor in developing coeliac disease, a hereditary autoimmune-like condition that affects about one in 70 Australians. It is estimated that half of all Australians are born with one of two genes that cause coeliac disease, and approximately one in 40 are likely to develop the condition. People […]

Discovery shines light on the cause of some allergic responses

A team of international researchers from Monash University, Columbia University and Harvard Medical School has discovered how some compounds contained in cosmetic and perfume products can activate human T cells, the sentinels of our immune system. It’s long been known that certain chemicals cause allergic contact dermatitis (ACD), but our understanding of why this is […]